Physician profile
Ellen Jane Carson
NPI 1447588678
$769.26
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $59.27 · 2022: $89.97 · 2023: $206 · 2024: $414.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $620.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $620.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Qol Medical, LLC | $241.17 | 2021-2024 | Sucraid, Sucraid |
| Genzyme Corporation | $155.32 | 2022-2024 | |
| Regeneron Healthcare Solutions, INC. | $65.70 | 2022-2023 | Dupixent |
| Abbvie INC. | $65.38 | 2021-2024 | |
| Ironwood Pharmaceuticals, INC | $53.83 | 2023-2024 | Linzess |
| Nestle Healthcare Nutrition INC. | $38.95 | 2021-2023 | |
| Ipsen Biopharmaceuticals, INC | $26.75 | 2023 | Bylvay |
| Pharming Healthcare, INC. | $23.70 | 2024 | Ruconest |
| Mirum Pharmaceuticals, INC. | $23.59 | 2024 | Livmarli |
| Aimmune Therapeutics, INC. | $22.08 | 2024 | |
| Vivus LLC | $17.90 | 2022 | |
| Rhythm Pharmaceuticals, INC. | $17.68 | 2022 | |
| Dentsply Ih Ab | $17.21 | 2024 | Navina Rectal Catheter Set Regular |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Carson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.